Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
search
Subscribe
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
Subscribe
FREE
29 Aug 2025
PD-1 Inhibitors Plus Chemotherapy Show Promise in Advanced Gastric Cancer
A new study finds that PD-1 inhibitors combined with chemotherapy achieved a 97.7% disease control rate and median progression-free survival of 13.5 months in advanced gastric cancer patients.
29 Aug 2025
Could Low Vitamin D Increase Thyroid Cancer Risk?
Lower vitamin D levels linked to higher thyroid cancer risk, new meta-analysis suggests clinical importance.
29 Aug 2025
Faecal Microbiota Transplant Beats Antibiotics in Recurrent
C. difficile
FMT and microbiome therapies significantly outperform antibiotics in recurrent C. difficile infection, with cure rates up to 91% and favourable long-term safety.
UK government establishes RNA Biofoundry
A £29.6 million government investment will establish the UK RNA Biofoundry in Darlington, providing manufacturing capacity to accelerate RNA therapies from lab to clinic.
29 Aug 2025
New AI System Boosts Accuracy in Skin Cancer Diagnosis
Clinical examination is limited by visual similarity between benign and malignant lesions and imperfect diagnostic accuracy.
7
Mins
29 Aug 2025
Optimising CAR-T Cell Therapy in RRMM
The ‘Mastering the Relapsed Refractory Multiple Myeloma (RRMM) Treatment Landscape: Removing Barriers and Unleashing the Potential of…
13
Mins
29 Aug 2025
Evidence on VNS in the Modern DRE Treatment Landscape
Epilepsy affects around 50 million people worldwide. Approximately 30% of them experience drug-resistant epilepsy (DRE), which…
13
Mins
28 Aug 2025
Patient-Reported Outcome Measures, 1 Year After COVID-19
Learn more about the long-term health effects persisting one year after COVID-19 infection, including fatigue, breathlessness…
Novo Nordisk taps Replicate’s srRNA platform for obesity
Novo Nordisk partners with Replicate Bioscience in a $550M srRNA deal to develop new therapies for obesity, diabetes and cardiometabolic diseases.
28 Aug 2025
CABANA Trial: Catheter Ablation Benefits Selected Patients with Atrial Fibrillation
Find out who benefits most from catheter ablation for atrial fibrillation according to new research. Keep reading to learn more.
←
1
2
3
…
49
50
51
52
53
54
55
…
1,327
1,328
1,329
→
We’ve noticed you’re accessing
from
North/South America.
View
View